Popular US remedy recalled over ‘life-threatening fungi' with kids most at risk
Nasal and baby teething swabs sold across the US have been recalled over fears of contamination with fungi.
Church & Dwight Co, Inc, announced on Friday it is recalling its Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs and Orajel Baby Teething Swabs on Friday 'due to potential microbial contamination identified as fungi in cotton swab components'.
The swabs that are contaminated 'can potentially present a significant risk to the health and safety of consumers including serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injuries', stated the announcement shared by the country's agency protecting public health.
All lots of the three products are under the recall.
Zicam Cold Remedy Nasal Swabs, designed to shorten the common cold, have the UPC number 732216301205. Zicam Nasal AllClear Swabs, meant for cleansing, were discontinued in December 2024 and have the UPC number 732216301656.
Orajel Baby Teething Swabs, designed to soothe discomfort from teething, have the UPC number 310310400002.
They were distributed nationwide and in Puerto Rico.
Customers should stop using the swabs immediately and contact the company for a full refund. More Trending
There have not been any reports of illness from the swabs, but any concerns should be flagged to the US Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program.
'The risk is highest (potentially severe or life-threatening) among children and individuals with compromised immune systems or other underlying medical conditions,' stated the notice from the FDA.
Church & Dwight describes itself as a $4.9billion 'leading manufacturer of consumer household and personal care products' based in Ewing, New Jersey.
It comes a few months after Ascent Consumer Products Inc recalled a lot of its SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System nationwide due to tests confirming microbial contamination with Staphylococcus aureus (S. aureus). That bacteria can also cause users with nasal mucosa inflammation or injuries to have blood infections.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Costco and Amazon fitness product sold almost 4,000,000 times recalled over broken bones
MORE: Mums 'in love triangle' fought in school playground in front of children
MORE: Popular clothing retailer to close almost 200 more stores in 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
5 hours ago
- Metro
Urgent recall for 19,000 Dr Pepper Zero Sugar cans over 'serious' health risk
More than 19,000 cans of Dr Pepper Zero Sugar have been recalled in the US over fears of 'serious adverse health consequences' to some consumers. The 19,203 cans have been recalled by Pepsi Beverages Company, which is licensed to manufacture Keurig Dr Pepper products, due to mislabeling. 'Product labeled to be Zero Sugar contains full sugar product,' states a notice published by the nation's agency tasked with ensuring food, drugs and products are safe for the public. People with diabetes and others who are sensitive to sugar could become seriously ill. The affected soda was packaged in aluminum cans and sold in packs of 12 and 24. They have the best by date of February 16, 2026, and the product code XXXXRS05165. More Trending They were shipped to three US states: Florida, Georgia and South Carolina. The company initiated a voluntary recall on May 23 of this year, but the US Food and Drug Administration (FDA) reclassified it to a Class II level on Thursday. A Class II recall is 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote', according to the FDA. The reclassification comes days after the Coca-Cola Company recalled 'limited quantities' of its Topo Chico mineral water sent to five US states over possible bacterial contamination. The affected Topo Chico bottles were sent to 40 retail locations in Arizona, Louisiana, Nevada, New Mexico and Texas. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Urgent recall of American sweets 'unsafe to eat and not compliant with UK law' MORE: Chemical spill at explosives plant sends massive orange plume into air in Ohio MORE: Leeds General Infirmary cordoned off after suspicious package is found
Daily Mail
9 hours ago
- Daily Mail
Thousands of cans of Dr Pepper recalled over risk of major health problems
Health officials have recalled 19,203 12-ounce cans of Dr Pepper Zero Sugar after discovering that they are 'full of sugar'. The Food and Drug Administration announced a voluntary recall of the 12-pack and 24-pack cases of Dr Pepper Zero Sugar last month. However, the federal agency updated the severity of the recall to Class II - meaning that the use of any Dr Pepper Zero Sugar can cause temporary or medically reversible adverse health consequences. The recalled cans were produced by the Pepsi Beverages Company in Jacksonville, Florida and were sold to retailers in Florida, Georgia and South Carolina. The term 'Zero Sugar' indicates that the product has been made with no sugar in any form. However, since these cans have been mislabeled and found to contain the same amount of sugar as a regular Dr Pepper can, they could create a health risk for diabetics or others who need to limit their sugar intake or avoid it altogether. A regular 12-ounce can of Dr. Pepper contains 39 grams of sugar, according to its nutrition facts label. The recalled Dr Pepper Zero Sugar cans have the product code XXXXRS05165 with a 'best by' date of Feb. 16, 2026. Although this notice doesn't advise what to do if with the recalled soda, the FDA notes on its website that recalled products can often be returned to the store where they were purchased. If that is not possible, the agency recommends safely disposing the product.
Reuters
11 hours ago
- Reuters
US FDA approves Nuvation Bio's lung cancer therapy
June 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's (NUVB.N), opens new tab therapy for patients with a type of lung cancer. The once-daily oral drug, with brand name Ibtrozi, is approved to treat ROS1-positive non-small cell lung cancer (NSCLC). NSCLC affects more than one million people globally, with about 2% having ROS1-positive disease, according to the company. The drug, taletrectinib, belongs to a class of drugs known as ROS1 inhibitors.
